Self Neuro-modulation Therapy for Major Depressive Disorder (MDD) With Anhedonia — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Self Neuro-modulation Therapy for Major Depressive Disorder (MDD) With Anhedonia — Stella

Home/Depressive Disorder, Major/

View on ClinicalTrials.gov

Recruiting

Back to Depressive Disorder, Major trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(3 sites)

United States

Butler Hospital, Providence, Rhode Island

Houston Center For Advanced Psychiatric Treatment, Houston, Texas

Israel

Sheba Medical Center, Ramat Gan

Key details

Sponsor

GrayMatters Health Ltd.

Enrollment target

~170 participants

Started

June 2025

Primary completion

May 2027

Age range

22 Years – 75 Years

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.